Tango Therapeutics, Inc. (TNGX)
23.34
-1.94
(-7.67%)
USD |
NASDAQ |
Aug 28, 16:00
23.35
+0.01
(+0.04%)
After-Hours: 20:00
Tango Therapeutics Cash from Operations (Quarterly) : -38.87M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -38.87M |
| March 31, 2026 | -44.36M |
| December 31, 2025 | -29.72M |
| September 30, 2025 | -30.95M |
| June 30, 2025 | -36.52M |
| March 31, 2025 | -41.70M |
| December 31, 2024 | -36.65M |
| September 30, 2024 | -33.39M |
| June 30, 2024 | -23.61M |
| March 31, 2024 | -37.86M |
| December 31, 2023 | -27.47M |
| September 30, 2023 | -31.14M |
| Date | Value |
|---|---|
| June 30, 2023 | -24.47M |
| March 31, 2023 | -34.91M |
| December 31, 2022 | -28.27M |
| September 30, 2022 | -19.61M |
| June 30, 2022 | -31.54M |
| March 31, 2022 | -29.66M |
| December 31, 2021 | -16.90M |
| September 30, 2021 | -21.49M |
| June 30, 2021 | -7.518M |
| March 31, 2021 | -13.61M |
| December 31, 2020 | -18.06M |
| September 30, 2020 | 88.14M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Revolution Medicines, Inc. | -387.32M |
| Erasca, Inc. | -27.27M |
| NovelStem International Corp. | -0.0336M |
| Brainstorm Cell Therapeutics, Inc. | -0.895M |
| Summit Therapeutics, Inc. | -140.55M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -445.97M |
| Cash from Financing (Quarterly) | 672.57M |
| Free Cash Flow | -144.27M |
| Free Cash Flow Per Share (Quarterly) | -0.2593 |
| Free Cash Flow to Equity (Quarterly) | -38.07M |
| Free Cash Flow to Firm (Quarterly) | -38.87M |
| Free Cash Flow Yield | -4.61% |